Formulation and in vitro evaluation of bisphosphonate loaded microspheres for implantation in osteolysis

Drug Development and Industrial Pharmacy

Volumn 32, Issue 4, 2006, Pages 473-481

  Samdancioglu, Sibel ^a   Calis, Sema ^a   Sumnu, Murat ^a   Hincal, A Atilla ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Alendronate sodium; Chitosan; Implants; Microspheres; Osteolysis; PLGA

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CHITOSAN; MICROSPHERE; POLYGLACTIN;

ARTICLE; BONE TISSUE; DENTAL SURGERY; DRUG FORMULATION; DRUG RELEASE; EMULSION; EVAPORATION; HUMAN; IMPLANTATION; IN VITRO STUDY; JOINT PROSTHESIS; OSTEOLYSIS; OSTEOPOROSIS; PARTICLE SIZE; PERIODONTITIS; POLYMERIZATION; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY;

ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DRUG IMPLANTS; EMULSIONS; LACTIC ACID; MICROSPHERES; OSTEOLYSIS; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; SOLUBILITY; SOLVENTS; SURFACE PROPERTIES;

EID: 33646473526     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040500528871     Document Type: Article

References (29)

1. Alex, R., & Bodmeier, R. (1990). Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. J. Microencapsul., 7(3), 347-355.
2. Arica, B., Calis, S., Kas, H. S., & Hincal, A. A. (2002a). Chitosan microspheres of ibuprofen: evaluation and in vitro characterization. In Chitosan in Pharmacy and Chemistry, Muzzarelli, R. A. A., & Muzzarelli, C., Eds.; Italy: Atec, 71-76.
3. Arica, B., Kas, H. S., Orman, M. N., & Hincal, A. A. (2002b). Biodegradable bromocryptine mesylate microspheres prepared by a solvent evaporation technique: I. Evaluation of formulation variables on microspheres characteristics for brain delivery. J. Microencapsul., 19(4), 473-484.
4. Bozdag, S., Capan, Y., Vural, I., Dalkara, T., Dogan, A. L., Guc, D., Hincal, A. A., & DeLuca, P. P. (2005). Formulation and in vitro bioactivity of mitoxantrone-loaded biodegradable microspheres on rat glioma (RG2) cells. J. Drug Del. Sci. Tech., 15(3), 201-206.
5. De Marco, J. D., Biffar, S. E., Reed, D. G., & Brooks, M. A. (1989). The determination of 4-amino-1-hydroxybutane-1,1-diphosphonic acid monosodium salt trihydrate in pharmaceutical dosage forms by high-performance liquid chromatography. J. Pharm. Biomed. Anal., 7(12), 1719-1727.
6. Ezra, A., & Golomb, G. (2000). Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption. Adv. Drug Deliver. Rev., 42, 175-195.
7. Fan, H., & Dash, A. K. (2001). Effect of cross-linking on the in vitro release kinetics of doxorubicin from gelatin implants. Int. J. Pharm., 213, 103-116.
8. Ghaderi, R., Sturesson, C., & Carlfors, J. (1996). Effect of preparative parameters on the characteristics of poly(D,L-lactide-co-glycolide) microspheres made by double emulsion method. Int. J. Pharm., 141, 205-216.
9. Golomb, G., Levi, M., & Van Gelder, J. M. (1992). Controlled release of bisphosphonate from a biodegradable implant: Evaluation of release kinetics and anticalcification effect. Journal of Applied Biomaterials, 3, 23-28.
10. Hennink, W. E., & Nostrum, C. F. (2002). Novel crosslinking methods to design hydrogels. Adv. Drug Deliver. Rev., 54, 13-36.
11. Herrmann, J., & Bodmeier, R. (1995). The effect of particle microstructure on the somastatin release from poly(lactide) microspheres prepared by a W/O/W solvent evaporation method. J. Control. Release, 36, 63-71.
12. Jain, R., Shah, N. H., Malick, A. W., & Rhodes, C. T. (1998). Controlled drug delivery by biodegradable poly (ester) devices: Different preparative approaches. Drug Dev. and Ind. Pharm., 24(8), 703-727.
13. Jain, R. A. (2000). The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials, 21, 2475-2490.
14. Kim, K. J., Rubash, H. E., Wilson, S. C., D'Antonio, J. A., & McClain, E. J. (1993). A histologic and biochemical comparison of the interface tissues in cementless and cemented hip prostheses. Clin. Orthop., 287, 142-152.
15. Leo, E., Pecquet, S., Rojas, J., Couvreur, P., & Fattal, E. (1998). Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method. J. Microencapsul., 15(4), 421-430.
16. Lin, J. H., Chen, I. W., & DeLuna, F. A. (1994). On the absorption of alendronate in rats. J. Pharm. Sci., 83(12), 1741-1746.
17. Mochida, Y., Bauer, T. W., Akisue, T., & Brown, P. R. (2002). Alendronate does not inhibit early bone apposition to hydroxyapatite-coated total joint implants. J. Bone Joint Surg., 84-A(2), 226-235.
18. O'Donnell, P. B., & McGinity, J. W. (1997). Preparation of microspheres by solvent evaporation technique. Adv. Drug Deliver. Rev., 28, 25-42.
19. Patashnik, S., Rabinovich, L., & Golomb, G. (1997). Preparation and evaluation of chitosan microspheres containing bisphosphonates. J. Drug Target, 4(6), 371-380.
20. Perugini, P., Genta, I., Conti, B., Modena, T., & Pavanetto, F. (2001). Long-term release of clodronate from biodegradable microspheres. AAPS Pharm. Sci. Tech., 2 (3), article 10, 1-9.
21. Ravi Kumar, M. N. V. (2000). A review of chitin and chitosan applications. Reactive & Functional Polymers, 46, 1-27.
22. Rosen, C. J., & Kessenich, C. R. (1996). Comparative clinical pharmacology and therapeutic use of bisphosphonates in metabolic bone diseases. Drugs, 51(4), 537-551.
23. Sabokbar, A., Fujikawa, Y., Murray, D. W., & Athanasou, N. A. (1998). Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption. Ann. Rheum. Dis., 57, 614-618.
24. Samdancioglu, S., Calis, S., Kir, S., & Sumnu, M. (2003). The determination of alendronate sodium in microparticular systems by high performance liquid chromatography. FABAD J. Pharm. Sci., 28(4), 183-192.
25. Sharpe, M., Noble, S., & Spencer, C. M. (2001). Alendronate: An update of its use in osteoporosis. Drugs, 61(7), 999-1039.
26. Thanoo, B.C., Sunny, M. C., & Jayakrishnan, A. (1992). Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J. Pharm. Pharmacol., 44, 283-286.
27. Tuncay, M., Calis, S., Kas, H. S., Ercan, M. T., Peksoy, I., & Hincal, A. A. (2000). Diclofenac sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro/in vivo evaluation. Int. J. Pharm., 195, 179-188.
28. Watts, P. J., Davies, M. C., & Melia, C. D. (1990). Microencapsulation using emulsification/solvent evaporation: an overview of techniques and applications. Crit. Rev. Drug Carrier Sys., 7(3), 235-258.
29. Yenice, I., Calis, S., Atilla, B., Kas, H. S., Ozalp, M., Ekizoglu, M., Bilgili, H., & Hincal, A. A. (2003). In vitro/in vivo evaluation of the efficiency of teicoplanin-loaded biodegradable microparticles formulated for implantation to infected bone defects. J. Microencapsul., 20(6), 705-717.